NCT01169311

Safety and Performance of the Covidien EEA Hemorrhoid and Prolapse Stapling Set in a Hemorrhoidopexy Procedure

A Prospective, Multi-Center Investigation Of The Safety And Performance Of The Covidien EEA™ Hemorrhoid And Prolapse Stapling Set With DST Series™ Technology Im A Hemorrhoidopexy Procedure

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 27 (actual)
• Sponsor: Medtronic - MITG · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Trial Objectives The primary objectives of this clinical trial are to estimate the Covidien EEA™ Hemorrhoid and Prolapse Stapling Set: overall performance defined by the successful creation of a normal staple line safety as measured by the 30 day incidence of adverse events.

Conditions

• Hemorrhoid

Interventions

Type	Name	Description
DEVICE	Hemorrhoidopexy

Timeline

• Start date: 2010-07-01
• Primary completion: 2011-03-01
• Completion: 2011-07-01
• First posted: 2010-07-26
• Last updated: 2014-10-06
• Results posted: 2014-10-06

Locations

1 site across 1 country: United States